3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcome
Ewan Hunter(Unknown), Alexandre Akoulitchev, William B. Messer(Oregon Health & Science University), Zoë L. Lyski(Oregon Health & Science University), Dmitri Pchejetski(University of East Anglia), Aroul Ramadass, Adam J. Wilson, Jane Mellor(University of Oxford), Paulina Brajer, Christina Koutsothanasi, Amanda E. Brunton(COPD Foundation), Jurjen W. Westra(Scripps Research Institute), Ann Dring, Ryan Powell, Peter A. Robbins(University of Oxford), Rama Vancheeswaran(Oxford University Hospitals NHS Trust), Francisco C. Santos, Matthew Salter, Andrew Barlow(West Hertfordshire Hospitals NHS Trust), Benedict Egan
Cited by 9
Related Papers
Natural selection on <i>EPAS1</i> ( <i>HIF2α</i> ) associated with low hemoglobin concentration in Tibetan highlanders
|Proceedings of the National Academy of Sciences|2010|854
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174